pioglitazone has been researched along with Diarrhea in 3 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Diarrhea: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pioglitazone is a peroxisome proliferator-activated receptor (PPAR) γ agonist and, although it is mostly used as an antidiabetic agent, it has been reported to have analgesic effects." | 5.40 | Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: role of nitric oxide. ( Azary, S; Dehpour, AR; Gharedaghi, MH; Javidan, AN; Kazemi, MH; Khalifeh-Soltani, A; Moradi, K; Paragomi, P; Rahimian, R; Sakuma, S, 2014) |
| "Pioglitazone is a peroxisome proliferator-activated receptor (PPAR) γ agonist and, although it is mostly used as an antidiabetic agent, it has been reported to have analgesic effects." | 1.40 | Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: role of nitric oxide. ( Azary, S; Dehpour, AR; Gharedaghi, MH; Javidan, AN; Kazemi, MH; Khalifeh-Soltani, A; Moradi, K; Paragomi, P; Rahimian, R; Sakuma, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paragomi, P | 1 |
| Rahimian, R | 1 |
| Kazemi, MH | 1 |
| Gharedaghi, MH | 1 |
| Khalifeh-Soltani, A | 1 |
| Azary, S | 1 |
| Javidan, AN | 1 |
| Moradi, K | 1 |
| Sakuma, S | 1 |
| Dehpour, AR | 1 |
| Bajwa, PJ | 1 |
| Lee, JW | 1 |
| Straus, DS | 1 |
| Lytle, C | 1 |
| Li, XJ | 1 |
| Yu, YX | 1 |
| Liu, CQ | 1 |
| Zhang, W | 1 |
| Zhang, HJ | 1 |
| Yan, B | 1 |
| Wang, LY | 1 |
| Yang, SY | 1 |
| Zhang, SH | 1 |
1 review available for pioglitazone and Diarrhea
| Article | Year |
|---|---|
Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis.
Topics: Dehydroepiandrosterone Sulfate; Diarrhea; Female; Humans; Hypoglycemic Agents; Metformin; Nausea; Pi | 2011 |
2 other studies available for pioglitazone and Diarrhea
| Article | Year |
|---|---|
Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: role of nitric oxide.
Topics: Analgesics; Animals; Antidiarrheals; Diarrhea; Disease Models, Animal; Irritable Bowel Syndrome; Mal | 2014 |
Activation of PPARgamma by rosiglitazone attenuates intestinal Cl- secretion.
Topics: Administration, Oral; Animals; Calcium; Carbachol; Chlorides; Cholera Toxin; Colforsin; Colon; Cycli | 2009 |